nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A four-week double-blind, placebo-controlled, parallel dose-response study of amlodipine in patients with stable exertional angina pectoris
|
Taylor, Stanley H. |
|
1989 |
118 |
5P2 |
p. 1133-1134 2 p. |
artikel |
2 |
A hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease
|
Taylor, Stanley H. |
|
1989 |
118 |
5P2 |
p. 1105-1106 2 p. |
artikel |
3 |
Amlodipine: A once-daily calcium antagonist in the treatment of angina pectoris—A parallel dose-response, placebo-controlled study
|
Thadani, Udho |
|
1989 |
118 |
5P2 |
p. 1135- 1 p. |
artikel |
4 |
Amlodipine in angina pectoris: Effect on maximal and submaximal exercise performance
|
Kinnard, David R. |
|
1989 |
118 |
5P2 |
p. 1136- 1 p. |
artikel |
5 |
Amlodipine versus nadolol in patients with stable angina pectoris
|
Singh, Steven |
|
1989 |
118 |
5P2 |
p. 1137-1138 2 p. |
artikel |
6 |
Antiischemic properties of amlodipine, a new calcium antagonist, in patients with severe coronary artery disease: A prospective trial
|
Estrada, JoséNavarro |
|
1989 |
118 |
5P2 |
p. 1130-1132 3 p. |
artikel |
7 |
Cardioprotective effects of amlodipine in the ischemic-reperfused heart
|
Lucchesi, Benedict R. |
|
1989 |
118 |
5P2 |
p. 1121-1122 2 p. |
artikel |
8 |
Circadian patterns of myocardial ischemia
|
Fox, Kim |
|
1989 |
118 |
5P2 |
p. 1084-1087 4 p. |
artikel |
9 |
Circadian rhythm of angina: Similarity to circadian rhythms of myocardial infarction, ischemic ST segment depression, and sudden cardiac death
|
Taylor, Colin R. |
|
1989 |
118 |
5P2 |
p. 1098-1099 2 p. |
artikel |
10 |
Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris
|
Glasser, Stephen P. |
|
1989 |
118 |
5P2 |
p. 1127-1128 2 p. |
artikel |
11 |
Double-blind crossover comparison of amlodipine at three dose levels and placebo in chronic stable angina
|
Deedwania, P. |
|
1989 |
118 |
5P2 |
p. 1132-1133 2 p. |
artikel |
12 |
Efficacy and safety of amlodipine in vasospastic angina: An interim report of a multicenter, placebo-controlled trial
|
Chahine, Robert A. |
|
1989 |
118 |
5P2 |
p. 1128-1130 3 p. |
artikel |
13 |
General discussion
|
|
|
1989 |
118 |
5P2 |
p. 1139- 1 p. |
artikel |
14 |
Hemodynamic and electrophysiologic effects of amlodipine, a new long-acting calcium antagonist: Preliminary observations
|
Vetrovec, G. |
|
1989 |
118 |
5P2 |
p. 1104-1105 2 p. |
artikel |
15 |
Introduction
|
Burkart, Felix E. |
|
1989 |
118 |
5P2 |
p. 1083- 1 p. |
artikel |
16 |
Pharmacodynamics of amlodipine: Hemodynamic effects and antianginal efficacy after atrial pacing
|
Hogg, Kerry J. |
|
1989 |
118 |
5P2 |
p. 1107-1113 7 p. |
artikel |
17 |
Silent myocardial ischemia
|
Droste, Conrad |
|
1989 |
118 |
5P2 |
p. 1087-1092 6 p. |
artikel |
18 |
Summary and closing remarks
|
Burkart, Felix E. |
|
1989 |
118 |
5P2 |
p. 1140- 1 p. |
artikel |
19 |
The efficacy of amlodipine in myocardial ischemia
|
Taylor, Stanley H. |
|
1989 |
118 |
5P2 |
p. 1123-1126 4 p. |
artikel |
20 |
The pharmacokinetic profile of amlodipine
|
Abernethy, Darrell R. |
|
1989 |
118 |
5P2 |
p. 1100-1103 4 p. |
artikel |
21 |
The role of calcium antagonists in the treatment of myocardial ischemia
|
Follath, Ferenc |
|
1989 |
118 |
5P2 |
p. 1093-1097 5 p. |
artikel |
22 |
The safety of amlodipine
|
Osterloh, Ian |
|
1989 |
118 |
5P2 |
p. 1114-1120 7 p. |
artikel |